Remarkably, all 12 patients reported significant improvement in symptoms and none reported adverse effects in the short term
Growth hormone plays an essential role in fat metabolism by stimulating lipolysis (the breakdown of stored fat into energy)
Some experts suggest that anti-obesity pharmacotherapy, including GLP-1 RAs, should become a primary treatment goal for individuals with diabetes, especially in the early stages
They aim to stimulate GLP-1 receptors, reduce appetite, and slow gastric emptying without injections
Patients with a history of lung diseases like asthma or chronic obstructive pulmonary disease (COPD) should use with caution and under medical supervision
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 149 , 112918